News for ACUR Stock

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03 Acura Pharmaceuticals Provides Development Update on LTX-03 Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03 Acura Pharmaceuticals Announces Conversion of Debt Acura Pharmaceuticals Provides Development Update on LTX-03 Acura Pharmaceuticals Announces First Quarter Ended March 31, 2021 Financial Results Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results